
MEA Ophthalmology Market - Industry Trends and Forecast to 2030
Description
MEA Ophthalmology Market - Industry Trends and Forecast to 2030
The Middle East & Africa Ophthalmology market is projected to register a substantial CAGR of 4.6 % in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentations
Middle East & Africa Ophthalmology Market, By Product Type (Device, Drugs, and Others), Diseases (Glaucoma, Cataract, Age-Related Macular Degeneration, Inflammatory Diseases, Refractive Disorders, and Others), Prescription Mode (Generic, and Branded), Drug Type (Prescription, and Over the Counter (OTC)), Route of Administration (Oral, Topical, Injectables, Local Ocular, and Others) End User (Hospitals, Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (South Africa, Saudi Arabia, UAE, Egypt, Israel, Kuwait, and Rest of Middle East and Africa), Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the Middle East & Africa Ophthalmology market are:
• Rising prevalence of ophthalmic disorders & ocular pains
• Increasing unhygienic & sedentary lifestyle
• The rise in traumatic injuries
• The rise in the geriatric population
Market Players
Some of the key market players for the Middle East & Africa Ophthalmology market are listed below:
• Johnson & Johnson Services, Inc.
• Novartis AG
• Bausch & Lomb Incorporated
• AbbVie Inc.
• Alcon
• Santen Pharmaceutical Co., Ltd.
• Others
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
The Middle East & Africa Ophthalmology market is projected to register a substantial CAGR of 4.6 % in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentations
Middle East & Africa Ophthalmology Market, By Product Type (Device, Drugs, and Others), Diseases (Glaucoma, Cataract, Age-Related Macular Degeneration, Inflammatory Diseases, Refractive Disorders, and Others), Prescription Mode (Generic, and Branded), Drug Type (Prescription, and Over the Counter (OTC)), Route of Administration (Oral, Topical, Injectables, Local Ocular, and Others) End User (Hospitals, Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (South Africa, Saudi Arabia, UAE, Egypt, Israel, Kuwait, and Rest of Middle East and Africa), Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the Middle East & Africa Ophthalmology market are:
• Rising prevalence of ophthalmic disorders & ocular pains
• Increasing unhygienic & sedentary lifestyle
• The rise in traumatic injuries
• The rise in the geriatric population
Market Players
Some of the key market players for the Middle East & Africa Ophthalmology market are listed below:
• Johnson & Johnson Services, Inc.
• Novartis AG
• Bausch & Lomb Incorporated
• AbbVie Inc.
• Alcon
• Santen Pharmaceutical Co., Ltd.
• Others
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
328 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The Middle East & Africa Ophthalmology Market
- 1.4 Currency And Pricing
- 1.5 Limitations
- 1.6 Markets Covered
- 2 Middle East & Africa Ophthalmology Market: Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Dbmr Tripod Data Validation Model
- 2.5 Primary Interviews With Key Opinion Leaders
- 2.6 Multivariate Modelling
- 2.7 Product Segment Lifeline Curve
- 2.8 Dbmr Market Position Grid
- 2.9 Vendor Share Analysis
- 2.10 Market End User Coverage Grid
- 2.11 Secondary Sources
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestel Analysis
- 4.2 Porter’s Five Forces
- 5 Epidemiology
- 6 Strategic Initiatives
- 7 Middle East & Africa Ophthalmology Market, Regulation
- 8 Market Overview
- 8.1 Drivers
- 8.1.1 Rising Prevalence Of Ophthalmic Disorders & Ocular Pains
- 8.1.2 Increasing Unhygienic & Sedentary Lifestyle
- 8.1.3 Rise In Traumatic Injuries
- 8.1.4 Rise In The Geriatric Population
- 8.2 Restraints
- 8.2.1 High Cost & Risks Associated With Eye Surgery & Treatment
- 8.2.2 Lack Of Health Insurance Amongst The Population, Especially Within The Developing Countries
- 8.2.3 Side Effects Associated With Treatment Drugs
- 8.3 Opportunities
- 8.3.1 Rise In Healthcare Expenditure And Disposable Income
- 8.3.2 Strategic Initiatives By Key Market Players
- 8.3.3 Rising Awareness To Prevent The Burden Of Eye Diseases
- 8.4 Challenge
- 8.4.1 Lack Of Skilled Professionals
- 8.4.2 Stringent Rules & Regulations For Product Approval
- 9 Middle East & Africa Ophthalmology Market, By Products
- 9.1 Overview
- 9.2 Device
- 9.2.1 Surgical Device
- 9.2.1.1 Cataract Surgical Devices
- 9.2.1.2 Ophthalmic Viscoelastic Devices
- 9.2.1.2.1 Phacoemulsification Devices
- 9.2.1.2.2 Cataract Surgical Lasers
- 9.2.1.2.3 Iol Injectors
- 9.2.1.3 Vitreoretinal Surgical Devices
- 9.2.1.3.1 Vitreoretinal Packs
- 9.2.1.3.2 Vitrectomy Machines
- 9.2.1.3.3 Vitrectomy Probes
- 9.2.1.3.4 Photocoagulation Lasers
- 9.2.1.3.5 Illumination Devices
- 9.2.1.4 Refractive Surgical Devices
- 9.2.1.4.1 Femtosecond Lasers
- 9.2.1.4.2 Excimer Lasers
- 9.2.1.4.3 Other Refractive Surgical Lasers
- 9.2.1.5 Glaucoma Surgical Devices
- 9.2.1.5.1 Glaucoma Drainage Devices
- 9.2.1.5.2 Glaucoma Laser Systems
- 9.2.1.5.3 Micro Invasive Glaucoma Surgery Devices
- 9.2.2 Diagnostic Device
- 9.2.2.1 Autorefractors & Keratometers
- 9.2.2.2 Tonometer
- 9.2.2.3 Phoropters
- 9.2.2.4 Retinoscopes
- 9.2.2.5 Ophthalmoscopes
- 9.2.2.6 Perimeters/Visual Field Analyzers
- 9.2.2.7 Ophthalmic Ultrasound Imaging Systems
- 9.2.2.7.1 A- Scan Imaging System
- 9.2.2.7.2 B-scan Imaging System
- 9.2.2.7.3 Pachymeters
- 9.2.2.7.4 Ultrasound Biomicroscopes
- 9.2.2.8 Lensmeters
- 9.2.2.9 Corneal Topography Systems
- 9.2.2.10 Optical Coherence Tomography Scanners
- 9.2.2.11 Fundus Cameras
- 9.2.2.12 Optical Biometry Systems
- 9.2.2.13 Specular Microscopes
- 9.2.2.14 Wavefront Aberrometers
- 9.2.2.15 Chart Projectors
- 9.2.2.16 Slit Lamps
- 9.2.3 Ophthalmic Surgical Accessories
- 9.2.3.1 Surgical Instruments & Kits
- 9.2.3.2 Ophthalmic Forceps
- 9.2.3.3 Ophthalmic Spatula
- 9.2.3.4 Ophthalmic Tips And Handles
- 9.2.3.5 Ophthalmic Cannulas
- 9.2.3.6 Ophthalmic Scissors
- 9.2.3.7 Others Surgical Accessories
- 9.2.4 Ophthalmic Microscopes
- 9.3 Drugs
- 9.3.1 Anti-inflammation Drugs
- 9.3.1.1 Non-steroidal Anti-inflammatory Drugs
- 9.3.1.2 Steroidal Anti-inflammatory Drugs
- 9.3.2 Allergic Conjunctivitis
- 9.3.3 Dry Eye Drugs
- 9.3.4 Retinal Disorder Drugs
- 9.3.5 Anti-glaucoma Drugs
- 9.3.5.1 Miotics
- 9.3.5.1.1 Pilocarpine
- 9.3.5.1.2 Eserine
- 9.3.5.2 Beta Adrenergic Antagonists
- 9.3.5.2.1 Timolal Maleate
- 9.3.5.2.2 Betaxolol
- 9.3.5.3 Prostaglandin Analogs
- 9.3.5.3.1 Latanoprost
- 9.3.5.3.2 Bimatoprost
- 9.3.5.3.3 Travoprost
- 9.3.5.3.4 Tafluprost
- 9.3.5.3.5 Latanoprostene
- 9.3.5.4 Alpha Adrenergic Agonists
- 9.3.5.4.1 Epinephrine
- 9.3.5.4.2 Depiveprine
- 9.3.5.5 Anti-vegf Drugs
- 9.3.5.5.1 Ranibizumab
- 9.3.5.5.2 Bevacizumab
- 9.3.6 Others
- 9.4 Others
- 9.4.1 Vision Care Products
- 9.4.1.1 Spectacles
- 9.4.1.2 Contact Lenses
- 9.4.1.2.1 Soft Contact Lenses
- 9.4.1.2.2 Hybrid Contact Lenses
- 9.4.1.2.3 Rigid Gas Permeable Lenses
- 9.4.2 Others
- 10 Middle East & Africa Ophthalmology Market, By Diseases
- 10.1 Overview
- 10.2 Inflammatory Diseases
- 10.3 Cataract
- 10.4 Refractive Disorders
- 10.5 Glaucoma
- 10.6 Age-related Macular Degeneration
- 10.7 Others
- 11 Middle East & Africa Ophthalmology Market, By Prescription Mode
- 11.1 Overview
- 11.2 Branded
- 11.3 Generic
- 12 Middle East & Africa Ophthalmology Market, By Drug Type
- 12.1 Overview
- 12.2 Over The Counter
- 12.3 Prescription
- 13 Middle East & Africa Ophthalmology Market, By Route Of Administration
- 13.1 Overview
- 13.2 Topical
- 13.2.1 Eye Drops
- 13.2.2 Eye Solution
- 13.2.3 Cream & Ointments
- 13.2.4 Gel
- 13.2.5 Others
- 13.3 Oral
- 13.3.1 Tablet
- 13.3.2 Capsules
- 13.3.3 Others
- 13.4 Local Ocular
- 13.4.1 Subconjunctival
- 13.4.2 Intravitreal
- 13.4.3 Retrobulbar
- 13.4.4 Intracameral
- 13.5 Injectable
- 13.5.1 Intramuscular
- 13.5.2 Intravenous
- 13.5.3 Others
- 13.6 Others
- 14 Middle East & Africa Ophthalmology Market, By End User
- 14.1 Overview
- 14.2 Clinics
- 14.3 Hospitals
- 14.4 Homecare Settings
- 14.5 Others
- 15 Middle East & Africa Ophthalmology Market, By Distribution Channel
- 15.1 Overview
- 15.2 Retail Sales
- 15.2.1 Retail Shops
- 15.2.2 Hospital Pharmacy
- 15.2.3 Online Pharmacy
- 15.3 Direct Tender
- 15.4 Others
- 16 Middle East & Africa Ophthalmology Market, By Geography
- 16.1 Middle East And Africa
- 16.1.1 South Africa
- 16.1.2 Saudi Arabia
- 16.1.3 U.A.E.
- 16.1.4 Egypt
- 16.1.5 Kuwait
- 16.1.6 Israel
- 16.1.7 Rest Of Middle East And Africa
- 17 Middle East & Africa Ophthalmology Market: Company Landscape
- 17.1 Company Share Analysis: Middle East & Africa
- 18 Swot Analysis
- 19 Company Profile
- 19.1 Alcon
- 19.1.1 Company Snapshot
- 19.1.2 Recent Financials
- 19.1.3 Company Share Analysis
- 19.1.4 Product Portfolio
- 19.1.5 Recent Developments
- 19.2 Regeneron Pharmaceuticals Inc.
- 19.2.1 Company Snapshot
- 19.2.2 Recent Financials
- 19.2.3 Company Share Analysis
- 19.2.4 Product Portfolio
- 19.2.5 Recent Development
- 19.3 Johnson & Johnson Services, Inc.
- 19.3.1 Company Snapshot
- 19.3.2 Recent Financials
- 19.3.3 Company Share Analysis
- 19.3.4 Product Portfolio
- 19.3.5 Recent Development
- 19.4 Reichert, Inc.
- 19.4.1 Company Snapshot
- 19.4.2 Company Share Analysis
- 19.4.3 Product Portfolio
- 19.4.4 Recent Development
- 19.5 Novartis Ag
- 19.5.1 Company Snapshot
- 19.5.2 Revenue Analysis
- 19.5.3 Company Share Analysis
- 19.5.4 Product Portfolio
- 19.5.5 Recent Developments
- 19.6 Abbvie Inc.
- 19.6.1 Company Snapshot
- 19.6.2 Recent Financials
- 19.6.3 Product Portfolio
- 19.6.4 Recent Development
- 19.7 Bausch & Lomb Incorporated
- 19.7.1 Company Snapshot
- 19.7.2 Revenue Analysis
- 19.7.3 Product Portfolio
- 19.7.4 Recent Developments
- 19.8 Carl Zeiss Meditec Ag
- 19.8.1 Company Snapshot
- 19.8.2 Revenue Analysis
- 19.8.3 Product Portfolio
- 19.8.4 Recent Developments
- 19.9 Essilorluxottica
- 19.9.1 Company Snapshot
- 19.9.2 Revenue Analysis
- 19.9.3 Product Portfolio
- 19.9.4 Recent Developmen
- 19.10 F. Hoffmann- La Roche Ltd
- 19.10.1 Company Snapshot
- 19.10.2 Revenue Analysis
- 19.10.3 Product Portfolio
- 19.10.4 Recent Development
- List Of Tables
- Table 1 Middle East & Africa Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 2 Middle East & Africa Device In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 3 Middle East & Africa Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 4 Middle East & Africa Surgical Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 5 Middle East & Africa Ophthalmic Viscoelastic Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 6 Middle East & Africa Vitreoretinal Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 7 Middle East & Africa Refractive Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 8 Middle East & Africa Glaucoma Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 9 Middle East & Africa Diagnostic Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 10 Middle East & Africa Ophthalmic Ultrasound Imaging Systems In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 11 Middle East & Africa Ophthalmic Surgical Accessories In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 12 Middle East & Africa Drugs In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 13 Middle East & Africa Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 14 Middle East & Africa Anti Inflammation Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 15 Middle East & Africa Anti Glaucoma Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 16 Middle East & Africa Miotics In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 17 Middle East & Africa Beta Adrenergic Antagonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 18 Middle East & Africa Prostaglandin Analogs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 19 Middle East & Africa Alpha Adrenergic Agonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 20 Middle East & Africa Anti-vegf Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 21 Middle East & Africa Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 22 Middle East & Africa Others In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 23 Middle East & Africa Vision Care Products In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 24 Middle East & Africa Contact Lenses In Ophthalmology Market, By Products, 2021-2030 (Usd Million))
- Table 25 Middle East & Africa Ophthalmology Market, By Diseases 2021-2030 (Usd Million)
- Table 26 Middle East & Africa Inflammatory Diseases In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 27 Middle East & Africa Cataract In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 28 Middle East & Africa Refractive Disorders In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 29 Middle East & Africa Glaucoma In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 30 Middle East & Africa Age-related Macular Degeneration In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 31 Middle East & Africa Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 32 Middle East & Africa Ophthalmology Market, By Prescription Mode, 2021-2030 (Usd Million)
- Table 33 Middle East & Africa Branded In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 34 Middle East & Africa Generic In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 35 Middle East & Africa Ophthalmology Market, By Drug Type 2021-2030 (Usd Million)
- Table 36 Middle East & Africa Over The Counter In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 37 Middle East & Africa Prescription In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 38 Middle East & Africa Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 39 Middle East & Africa Topical In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 40 Middle East & Africa Topical In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 41 Middle East & Africa Oral In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 42 Middle East & Africa Oral In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 43 Middle East & Africa Local Ocular In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 44 Middle East & Africa Local Ocular In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 45 Middle East & Africa Injectables In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 46 Middle East & Africa Injectables In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 47 Middle East & Africa Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 48 Middle East & Africa Ophthalmology Market, By End User, 2021-2030 (Usd Million)
- Table 49 Middle East & Africa Clinics In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 50 Middle East & Africa Hospitals In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 51 Middle East & Africa Home Healthcare In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 52 Middle East & Africa Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 53 Middle East & Africa Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 54 Middle East & Africa Retail Sales In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 55 Middle East & Africa Retail Sales In Ophthalmology Market, By Distribution Channel 2021-2030 (Usd Million)
- Table 56 Middle East & Africa Direct Tender In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 57 Middle East & Africa Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 58 Middle East And Africa Ophthalmology Market, By Country, 2021-2030 (Usd Million)
- Table 59 Middle East And Africa Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 60 Middle East And Africa Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 61 Middle East And Africa Surgical Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 62 Middle East And Africa Ophthalmic Viscoelastic Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 63 Middle East And Africa Vitreoretinal Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 64 Middle East And Africa Refractive Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 65 Middle East And Africa Glaucoma Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 66 Middle East And Africa Diagnostic Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 67 Middle East And Africa Ophthalmic Ultrasound Imaging Systems In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 68 Middle East And Africa Ophthalmic Surgical Accessories In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 69 Middle East And Africa Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 70 Middle East And Africa Anti-inflammation Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 71 Middle East And Africa Anti-glaucoma Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 72 Middle East And Africa Miotics In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 73 Middle East And Africa Beta Adrenergic Antagonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 74 Middle East And Africa Prostaglandin Analogs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 75 Middle East And Africa Alpha Adrenergic Agonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 76 Middle East And Africa Anti-vegf Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 77 Middle East And Africa Others In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 78 Middle East And Africa Vision Care Products In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 79 Middle East And Africa Contact Lenses In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 80 Middle East And Africa Ophthalmology Market, By Diseases, 2021-2030 (Usd Million)
- Table 81 Middle East And Africa Ophthalmology Market, By Prescription Mode, 2021-2030 (Usd Million)
- Table 82 Middle East And Africa Ophthalmology Market, By Drug Type, 2021-2030 (Usd Million)
- Table 83 Middle East And Africa Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 84 Middle East And Africa Topical In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 85 Middle East And Africa Oral In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 86 Middle East And Africa Local Ocular In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 87 Middle East And Africa Injectables In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 88 Middle East And Africa Ophthalmology Market, By End User, 2021-2030 (Usd Million)
- Table 89 Middle East And Africa Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 90 Middle East And Africa Retail Sales In Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 91 South Africa Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 92 South Africa Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 93 South Africa Surgical Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 94 South Africa Ophthalmic Viscoelastic Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 95 South Africa Vitreoretinal Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 96 South Africa Refractive Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 97 South Africa Glaucoma Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 98 South Africa Diagnostic Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 99 South Africa Ophthalmic Ultrasound Imaging Systems In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 100 South Africa Ophthalmic Surgical Accessories In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 101 South Africa Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 102 South Africa Anti-inflammation Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 103 South Africa Anti-glaucoma Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 104 South Africa Miotics In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 105 South Africa Beta Adrenergic Antagonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 106 South Africa Prostaglandin Analogs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 107 South Africa Alpha Adrenergic Agonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 108 South Africa Anti-vegf Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 109 South Africa Others In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 110 South Africa Vision Care Products In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 111 South Africa Contact Lenses In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 112 South Africa Ophthalmology Market, By Diseases, 2021-2030 (Usd Million)
- Table 113 South Africa Ophthalmology Market, By Prescription Mode, 2021-2030 (Usd Million)
- Table 114 South Africa Ophthalmology Market, By Drug Type, 2021-2030 (Usd Million)
- Table 115 South Africa Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 116 South Africa Topical In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 117 South Africa Oral In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 118 South Africa Local Ocular In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 119 South Africa Injectables In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 120 South Africa Ophthalmology Market, By End User, 2021-2030 (Usd Million)
- Table 121 South Africa Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 122 South Africa Retail Sales In Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 123 Saudi Arabia Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 124 Saudi Arabia Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 125 Saudi Arabia Surgical Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 126 Saudi Arabia Ophthalmic Viscoelastic Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 127 Saudi Arabia Vitreoretinal Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 128 Saudi Arabia Refractive Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 129 Saudi Arabia Glaucoma Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 130 Saudi Arabia Diagnostic Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 131 Saudi Arabia Ophthalmic Ultrasound Imaging Systems In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- List Of Figures
- Figure 1 Middle East & Africa Ophthalmology Market: Segmentation
- Figure 2 Middle East & Africa Ophthalmology Market: Data Triangulation
- Figure 3 Middle East & Africa Ophthalmology Market: Droc Analysis
- Figure 4 Middle East & Africa Ophthalmology Market: Middle East & Africa Vs Regional Market Analysis
- Figure 5 Middle East & Africa Ophthalmology Market: Company Research Analysis
- Figure 6 Middle East & Africa Ophthalmology Market: Interview Demographics
- Figure 7 Middle East & Africa Ophthalmology Market: Dbmr Position Grid
- Figure 8 Middle East & Africa Ophthalmology Market: Vendor Share Analysis
- Figure 9 Middle East & Africa Ophthalmology Market: End User Coverage Grid
- Figure 10 Middle East & Africa Ophthalmology Market: Segmentation
- Figure 11 Rising Prevalence Of Ophthalmic Disorders& Increasing Geriatric Population Are Expected To Drive The Middle East & Africa Ophthalmology Market From 2022 To 2029
- Figure 12 The Device Segment Is Expected To Have The Largest Share Of The Middle East & Africa Ophthalmology Market From 2022 To 2029
- Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Middle East & Africa Ophthalmology Market
- Figure 14 Middle East & Africa Ophthalmology Market: By Products, 2022
- Figure 15 Middle East & Africa Ophthalmology Market: By Products, 2023-2030 (Usd Million)
- Figure 16 Middle East & Africa Ophthalmology Market: By Products, Cagr (2023-2030)
- Figure 17 Middle East & Africa Ophthalmology Market: By Products, Lifeline Curve
- Figure 18 Middle East & Africa Ophthalmology Market: By Diseases, 2022
- Figure 19 Middle East & Africa Ophthalmology Market: By Diseases, 2023-2030 (Usd Million)
- Figure 20 Middle East & Africa Ophthalmology Market: By Diseases, Cagr (2023-2030)
- Figure 21 Middle East & Africa Ophthalmology Market: By Diseases, Lifeline Curve
- Figure 22 Middle East & Africa Ophthalmology Market: By Prescription Mode ,2022
- Figure 23 Middle East & Africa Ophthalmology Market: By Prescription Mode, 2023-2030 (Usd Million)
- Figure 24 Middle East & Africa Ophthalmology Market: By Prescription Mode, Cagr (2023-2030)
- Figure 25 Middle East & Africa Ophthalmology Market: By Prescription Mode, Lifeline Curve
- Figure 26 Middle East & Africa Ophthalmology Market: By Drug Type ,2022
- Figure 27 Middle East & Africa Ophthalmology Market: By Drug Type, 2023-2030 (Usd Million)
- Figure 28 Middle East & Africa Ophthalmology Market: By Drug Type, Cagr (2023-2030)
- Figure 29 Middle East & Africa Ophthalmology Market: By Drug Type, Lifeline Curve
- Figure 30 Middle East & Africa Ophthalmology Market: By Route Of Administration, 2022
- Figure 31 Middle East & Africa Ophthalmology Market: By Route Of Administration, 2023-2030 (Usd Million)
- Figure 32 Middle East & Africa Ophthalmology Market: By Route Of Administration, Cagr (2023-2030)
- Figure 33 Middle East & Africa Ophthalmology Market : By Route Of Administration, Lifeline Curve
- Figure 34 Middle East & Africa Ophthalmology Market: By End User, 2022
- Figure 35 Middle East & Africa Ophthalmology Market: By End User, 2023-2030 (Usd Million)
- Figure 36 Middle East & Africa Ophthalmology Market: By End User, Cagr (2023-2030)
- Figure 37 Middle East & Africa Ophthalmology Market: By End User, Lifeline Curve
- Figure 38 Middle East & Africa Ophthalmology Market: By Distribution Channel, 2022
- Figure 39 Middle East & Africa Ophthalmology Market: By Distribution Channel, 2023-2030 (Usd Million)
- Figure 40 Middle East & Africa Ophthalmology Market: By Distribution Channel, Cagr (2023-2030)
- Figure 41 Middle East & Africa Ophthalmology Market: By Distribution Channel, Lifeline Curve
- Figure 42 Middle East And Africa Ophthalmology Market: Snapshot (2022)
- Figure 43 Middle East And Africa Ophthalmology Market: By Country (2022)
- Figure 44 Middle East And Africa Ophthalmology Market: By Country (2023 & 2030)
- Figure 45 Middle East And Africa Ophthalmology Market: By Country (2022 & 2030)
- Figure 46 Middle East And Africa Ophthalmology Market: Products (2023-2030)
- Figure 47 Middle East & Africa Ophthalmology Market: Company Share 2022 (%) 217
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.